Clinical Trials Browser

Phase 1/2 × NIH × plerixafor × Clear all

NCT05470491 2026-06-05

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

Phase 1/2 Recruiting

Other hematologic neoplasm

Acquired Immunodeficiency Syndrome, Hematologic Neoplasms

NCT00967785 2026-05-22

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

Phase 1/2 Recruiting

Agammaglobulinemia, Immunologic Deficiency Syndromes, Infections, Leukopenia, Neutropenia, Warts